Clinical Trial Update: A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (HINATA) comparing follitropin alfa/lutropin alfa versus hMG in Japanese participants with LH and FSH deficiency undergoing ART; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Infertility

Drugs mentioned

• Follitropin alfa/Lutropin alfa (recombinant FSH and recombinant LH)
• hMG (human menopausal gonadotropin)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 3 | Status: RECRUITING